Researchers conducted a phase 2 trial to assess the safety and efficacy of single-dose psilocybin treatment for major depressive disorder.
Your search for major depressive disorder returned 66 results
Click on a filter below to refine your search. Remove a filter to broaden your search.
An umbrella review assessed the safety and efficacy of antidepressants in patients with depression and comorbid medical diseases.
Researchers investigated the all-cause risk for mortality in patients with major depressive disorder exhibiting suicidal behavior.
Review authors aimed to assess the effect of educational interventions on knowledge acquisition and health outcomes in adolescents with feeding and eating disorders.
Researchers sought to evaluate the safety of COVID-19 vaccination in pregnant and breastfeeding women with autoimmune diseases.
An eye-tracking test has identified a potential performance-based biomarker for the early diagnosis of autism spectrum disorder (ASD).
A study sought to determine the prevalence of depression and cognitive dysfunction in patients receiving TAVR for aortic stenosis and its effect on mortality.
Researchers evaluated the risk for major depressive disorder among patients with HIV infection.
A study was conducted to determine the effect of mental health disorders on postoperative outcomes following EVAR in patients who are veterans.
Ulotaront is a trace amine-associated receptor 1 agonist with 5-HT1A agonist activity.
Researchers assessed characteristics and correlates of metabolic syndrome in adolescents with major depressive disorder or bipolar disorder depression.
Researchers seek to evaluate whether trauma-focused therapy adjunctive to treatment as usual (TAU) leads to a greater reduction of depressive symptoms posttreatment vs TAU exclusively in patients with major depressive disorder with childhood trauma.
Researchers compared the white matter networks of patients with remitted major depressive disorder and remitted bipolar disorder to find disease-specific alterations.
Investigators searched publication databases for randomized controlled trials evaluating cognitive training and remediation interventions among patients with MDD.
Investigators sourced data for this study from the Stockholm Major Depressive Disorder Cohort. Between 2010 and 2018, all patients in the Stockholm region who met the criteria for MDD were enrolled in the cohort.
Some men have said that honest communication and community-based approaches make them more like to engage in mental health care.
Researchers examined correlations between suicidal ideation and suicide attempt history in patients with treatment-resistant depression following ketamine infusion.
Researchers examined long-term associations between COVID-19 infection and the risk of mortality and multiorgan complications among older adults.
Patients who had treatment-naïve MDD were recruited in the US between 2007 and 2013 for the Predictors of Remission in Depression to Individual and Combined Treatments (PReDICT) study.
Researchers assessed whether clinical severity and instability, during a 2-month period, were predictors of later risk for psychiatric hospitalization within the next 6 months.
Patients with MDD were randomly assigned in a 1:1:1 ratio to receive 1.5 mg daily cariprazine, 3.0 mg daily cariprazine, or placebo for 6 weeks.
The FDA has approved Rexulti (brexpiprazole) for the treatment of agitation associated with dementia due to Alzheimer disease.
A study was conducted to determine the effects of switching or augmenting antidepressant therapy in adults with treatment-resistant depression.
Investigators looked into which treatment fared better for patients with anxiety disorders: a mindfulness-based stress reduction intervention or escitalopram.
Investigators assessed the prevalence of exposure to medications with potential drug-drug interactions to ritonavir-containing COVID-19 therapy among US adults.
Investigators sought to assess associations for US Army soldiers bullied by fellow soldiers with mental health outcomes.
Anxiety, depressive, and panic disorders are all common psychiatric comorbidities found in patients with migraine and headache disorders.
A placebo-controlled study of smokers with MDD evaluated varenicline with vs without behavioral interventions for smoking cessation.
The REAL-ESK study was an observational, retrospective, multicenter study conducted in Italy.